Noteworthy events during the week of March 8 – 14 for healthcare investors.
SUNDAY (3/8): Conference on Retroviruses and Opportunistic Infections, Boston (4 days). CytoDyn (OTCQB:CYDY): Preclinical on PRO 140 supporting preexposure prophylaxis.
TUESDAY (3/10): FDA action date for Bristol-Myers Squibb‘s (NYSE:BMY)
Opdivo (nivolumab) + Yervoy (ipilimumab) for advanced hepatocellular
carcinoma patients who have previously received Bayer’s Nexavar
(sorafenib).
WEDNESDAY (3/11): European Neuroendocrine Tumor Society Annual Conference, Barcelona (3 days).
THURSDAY (3/12): Aridis Pharmaceuticals (NASDAQ:ARDS) Investor Day, NYC.
FRIDAY (3/13): American Academy of Asthma, Allergy and Immunology Annual Meeting, Philadelphia (4 days).
SATURDAY (3/14): FDA action for Merck‘s (NYSE:MRK) Ebola vaccine.
https://seekingalpha.com/news/3549367-key-events-next-week-healthcare
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.